CNS Pharmaceuticals, Inc. (CNSP) Free cash flow 2018–2025
CNS Pharmaceuticals, Inc. (CNSP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$13.8MFY2025 · since FY2018: -$716,385 → -$13.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.8M | +19.2% |
| FY2024 | -$17.1M | -21.0% |
| FY2023 | -$14.1M | -33.9% |
| FY2022 | -$10.6M | +22.0% |
| FY2021 | -$13.5M | -84.6% |
| FY2020 | -$7.3M | -105.3% |
| FY2019 | -$3.6M | -398.8% |
| FY2018 | -$716,385 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice